Shoji Nagao

ORCID: 0000-0003-4031-8091 · 3 papers in corpus
diagnostic-accuracy 2021
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
International journal of clinical oncology ·doi:10.1007/s10147-021-01914-y

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we exam…

observational 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.08.007

OBJECTIVE: To examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer. METHODS: This multicenter retrospective study examined women aged <5…

case-report 2015
A case of endometrial cancer detected incidentally after a total laparoscopic hysterectomy for adenomyosis
·doi:10.5180/jsgoe.31.244

We present a case of endometrial cancer detected incidentally after a total laparoscopic hysterectomy for adenomyosis. A 45-year-old woman was referred to our department with the chief complaint of hypermenorrhea, abnormal genital bleeding,…